This is consistent with DNMT3A mutations appearing rarely in tissue biopsies, and tending to appear only in high TMB tissue samples, often as passenger disruptions of the gene, but appearing frequently in liquid biopsies regardless of tumor mutational burden (Fig. 3A-D). This evidence concerns the gene DNMT3A and neoplasm.